JL15003Injection not checked

Jecho Biopharmaceuticals Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Intratumoral or intracavitary administration of JL15003 Injection as needed”In the company’s words, NCT07501559 on ClinicalTrials.gov
Tested for
Recurrent Glioblastoma Multiforme(GBM)
Main trialPhase 1/2
“The goal of this clinical trial is to evaluate the safety and efficacy of JL15003 Injection in subjects with recurrent glioblastoma (rGMB).”In the company’s words, NCT07501559 on ClinicalTrials.gov

Other drugs for Recurrent Glioblastoma Multiforme(GBM)

All 94 drugs for Recurrent Glioblastoma Multiforme(GBM)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting Apr 2030 A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow JL15003Injection

Following is part of Solo: you see every change to JL15003Injection the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in